Description
THE PURPOSE OF THIS MODIFICATION IS TO DECREASE CONTRACT LINE-ITEM NUMBER 0001, REMOVE EXCESS QUANTITIES, DE-OBLIGATE ASSOCIATED FUNDS, AND CLOSE OUT THE TASK ORDER.
Base award description: VHA BREAST CANCER MOLECULAR TESTING BPA
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-08-27+$497,370= $497,370
- Mod P000012025-12-10-$58,717= $438,653
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-08-27 | +$497,370 | $497,370 | VHA BREAST CANCER MOLECULAR TESTING BPA |
| Mod P00001· CLOSE OUT | 2025-12-10 | −$58,717 | $438,653 | THE PURPOSE OF THIS MODIFICATION IS TO DECREASE CONTRACT LINE-ITEM NUMBER 0001, REMOVE EXCESS QUANTITIES, DE-O… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NGBXEJX5GLE9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0419 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $127,174 | FY2026 |
| 36C25726N0252 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $52,215 | FY2026 |
| 36C25526N0057 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0056 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0054 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $24,259 | FY2026 |
| 36C25526N0055 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,116 | FY2026 |
Other recipients under Q301 from SAC FREDERICK (36C10X) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C10X25N0264 | BAYLOR MIRACA GENETICS LABORATORIES LLC | SAC FREDERICK (36C10X) | $11,387,675 | FY2025 |
| 36C10X25N0265 | FULGENT THERAPEUTICS LLC | SAC FREDERICK (36C10X) | $6,573,600 | FY2025 |
| 36C10X24N0227 | FULGENT THERAPEUTICS LLC | SAC FREDERICK (36C10X) | $2,949,000 | FY2024 |
| 36C10X24D0028 | FULGENT THERAPEUTICS LLC | SAC FREDERICK (36C10X) | $0 | FY2024 |
| 36C10X24N0226 | BAYLOR MIRACA GENETICS LABORATORIES LLC | SAC FREDERICK (36C10X) | $344,429 | FY2024 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C10X24F0099_3600_36C10X24A0011_3600 · retrieved 2026-09-26.